← Back to Search

Paravertebral Block for Pancreatic Surgery

Phase 4
Recruiting
Led By John Stauffer, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Nonpregnant adults undergoing open pancreaticoduodenectomy via standard upper midline incision without contraindications to para vertebral block (PVB)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 48 hours after surgery
Awards & highlights

Study Summary

This trial will compare pain control during & after open pancreatic surgery. Data will be recorded for length of stay & complications to improve patient outcomes.

Who is the study for?
This trial is for nonpregnant adults who are about to have open pancreaticoduodenectomy surgery and can give consent. It's not for those with chronic pain on daily opiates, opiate intolerance, or allergies to pain meds like NSAIDs, acetaminophen, or local anesthetics.Check my eligibility
What is being tested?
The study compares the effectiveness of a Paravertebral block (PVB) using Ropivacaine versus no block in managing pain during and after pancreaticoduodenectomy. The length of hospital stay and complications will also be tracked.See study design
What are the potential side effects?
Possible side effects from Ropivacaine may include nausea, low blood pressure, allergic reactions, nerve damage or infection at the injection site but these vary among individuals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult not pregnant and can have a surgery on my pancreas with a specific pain block.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 48 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and first 48 hours after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean post-operative pain score
Secondary outcome measures
Hospital Length of Stay
Number of subjects with a bowel obstruction

Trial Design

2Treatment groups
Active Control
Group I: Paravertebral Block Pre ProcedureActive Control1 Intervention
Subject will receive a preoperative paravertebral block only
Group II: No Paravertebral BlockActive Control1 Intervention
Subject will receive no paravertebral block.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,191 Previous Clinical Trials
3,758,452 Total Patients Enrolled
John Stauffer, M.D.Principal InvestigatorMayo Clinic

Media Library

Paravertebral Block Pre Procedure Clinical Trial Eligibility Overview. Trial Name: NCT05820997 — Phase 4
Pancreaticoduodenectomy Research Study Groups: Paravertebral Block Pre Procedure, No Paravertebral Block
Pancreaticoduodenectomy Clinical Trial 2023: Paravertebral Block Pre Procedure Highlights & Side Effects. Trial Name: NCT05820997 — Phase 4
Paravertebral Block Pre Procedure 2023 Treatment Timeline for Medical Study. Trial Name: NCT05820997 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any potential risks associated with employing a Paravertebral Block Pre Procedure?

"Paravertebral Block Pre Procedure has been greenlit for use, so it achieved a score of 3."

Answered by AI

Are there still opportunities to participate in this experiment for willing subjects?

"According to clinicaltrials.gov, this trial has finished recruiting and is not currently seeking candidates. Posted on April 13th 2023 and last updated on April 6th 2023, 11 other studies are actively enrolling patients at the moment."

Answered by AI
~17 spots leftby Dec 2024